5-Feb-2025 7:16 AM CST - Business Insider D.A. Davidson Sticks to Its Hold Rating for Clorox (CLX) In a report released today, Linda Bolton Weiser from D.A. Davidson maintained a Hold rating on Clorox (CLX - Research Report), with a price
5-Feb-2025 7:15 AM CST - MSN The Clorox Company (NYSE:CLX) Q2 2025 Earnings Call Transcript Q2 2025 Earnings Call Transcript February 3, 2025 The Clorox Company beats earnings expectations. Reported EPS is $1.55, expectations were $1.39. Operator: Good day, ladies and gentlemen, and welcome to The Clorox Company Second Quarter Fiscal Year 2025 Earnings Release Conference Call.
5-Feb-2025 7:10 AM CST - Business Insider Clorox price target lowered to $169 from $171 at DA Davidson DA Davidson lowered the firm's price target on Clorox (CLX) to $169 from $171 and keeps a Neutral rating on the shares. The company reported a
5-Feb-2025 4:36 AM CST - Business Insider Clorox price target raised to $140 from $130 at Barclays Barclays analyst Lauren Lieberman raised the firm's price target on Clorox (CLX) to $140 from $130 and keeps an Underweight rating on the
4-Feb-2025 2:06 PM CST - StockStory.org Why Clorox (CLX) Shares Are Getting Obliterated Today Shares of consumer products giant Clorox (NYSE:CLX) fell 7% in the afternoon session after the company reported underwhelming fourth quarter results, with revenue down 15%, reflecting inventory normalization and the sale of the Better Health Vitamins,
4-Feb-2025 1:27 PM CST - Seeking Alpha Clorox shares under pressure as cautious outlook overshadows FQ2 beat Shares of Clorox (NYSE:CLX) were under heavy selling pressure Tuesday and dipped below support at the 200-day moving average for the first time since August as the company's above-consensus fiscal Q2 results were overshadowed by a double-digit drop in sales,
4-Feb-2025 11:26 AM CST - Benzinga Clorox Analysts Boost Their Forecasts Following Upbeat Earnings Clorox Company CLX reported better-than-expected second-quarter financial results Monday after the bell. Clorox reported fiscal second-quarter revenue of $1.69 billion, beating the consensus estimate of $1.
4-Feb-2025 8:57 AM CST - Zacks Clorox Beats Q2 Earnings & Sales Estimates, Updates FY25 Outlook The Clorox Company CLX reported second-quarter fiscal 2025 results, wherein the top and bottom lines surpassed the Zacks Consensus Estimate. However, revenues and earnings declined year over year. Clorox's second-quarter fiscal 2025 results highlight a mix of strategic transformation and post-cyberattack recovery.
5-Feb-2025 7:16 AM CST - Business Insider D.A. Davidson Sticks to Its Hold Rating for Clorox (CLX) In a report released today, Linda Bolton Weiser from D.A. Davidson maintained a Hold rating on Clorox (CLX - Research Report), with a price
5-Feb-2025 7:15 AM CST - MSN The Clorox Company (NYSE:CLX) Q2 2025 Earnings Call Transcript Q2 2025 Earnings Call Transcript February 3, 2025 The Clorox Company beats earnings expectations. Reported EPS is $1.55, expectations were $1.39. Operator: Good day, ladies and gentlemen, and welcome to The Clorox Company Second Quarter Fiscal Year 2025 Earnings Release Conference Call.
5-Feb-2025 7:10 AM CST - Business Insider Clorox price target lowered to $169 from $171 at DA Davidson DA Davidson lowered the firm's price target on Clorox (CLX) to $169 from $171 and keeps a Neutral rating on the shares. The company reported a
5-Feb-2025 4:36 AM CST - Business Insider Clorox price target raised to $140 from $130 at Barclays Barclays analyst Lauren Lieberman raised the firm's price target on Clorox (CLX) to $140 from $130 and keeps an Underweight rating on the
4-Feb-2025 2:06 PM CST - StockStory.org Why Clorox (CLX) Shares Are Getting Obliterated Today Shares of consumer products giant Clorox (NYSE:CLX) fell 7% in the afternoon session after the company reported underwhelming fourth quarter results, with revenue down 15%, reflecting inventory normalization and the sale of the Better Health Vitamins,
4-Feb-2025 1:27 PM CST - Seeking Alpha Clorox shares under pressure as cautious outlook overshadows FQ2 beat Shares of Clorox (NYSE:CLX) were under heavy selling pressure Tuesday and dipped below support at the 200-day moving average for the first time since August as the company's above-consensus fiscal Q2 results were overshadowed by a double-digit drop in sales,
4-Feb-2025 11:26 AM CST - Benzinga Clorox Analysts Boost Their Forecasts Following Upbeat Earnings Clorox Company CLX reported better-than-expected second-quarter financial results Monday after the bell. Clorox reported fiscal second-quarter revenue of $1.69 billion, beating the consensus estimate of $1.
4-Feb-2025 8:57 AM CST - Zacks Clorox Beats Q2 Earnings & Sales Estimates, Updates FY25 Outlook The Clorox Company CLX reported second-quarter fiscal 2025 results, wherein the top and bottom lines surpassed the Zacks Consensus Estimate. However, revenues and earnings declined year over year. Clorox's second-quarter fiscal 2025 results highlight a mix of strategic transformation and post-cyberattack recovery.